SCHEMBL31601710

SCHEMBL31601710

CCOC(=O)CN(Cc1ccc(OC)cc1)c1cc(N2CC3CC(C2)N3C(=O)OC(C)(C)C)nn2c(C(F)(F)F)cnc12

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CETP P11597 3/20 0.36
▸ GPR119 Q8TDV5 3/20 0.34
▸ RET P07949 2/20 0.34
▸ POLB P06746 1/20 0.33
▸ RXFP1 Q9HBX9 1/20 0.33
▸ F2 P00734 3/20 0.32
▸ F10 P00742 3/20 0.32
▸ HCRTR2 O43614 1/20 0.32
▸ JAK2 O60674 1/20 0.32
▸ JAK1 P23458 1/20 0.32
▸ TYK2 P29597 1/20 0.32
▸ JAK3 P52333 1/20 0.32
▸ SLC2A1 P11166 1/20 0.31
▸ HDAC1 Q13547 1/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ ITGB3 P05106 1/20 0.31
▸ ITGA2B P08514 1/20 0.31
▸ KDM4E B2RXH2 1/20 0.30
▸ ALDH1A1 P00352 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31601908 0.89 POLB (0.35) CETPGPR119POLBRXFP1F2
SCHEMBL31601688 0.88 HPGD (0.38) GPR119POLBRXFP1SLC2A1MEN1
SCHEMBL31601954 0.85 POLB (0.36) POLBRXFP1F2F10KDM4E
SCHEMBL31601738 0.84 CNR2 (0.36) POLBRXFP1F10KDM4EALDH1A1
SCHEMBL31601920 0.83 DGAT1 (0.42) POLBRXFP1KDM4EALDH1A1
SCHEMBL31601804 0.83 POLB (0.37) POLBRXFP1F2F10KDM4E
SCHEMBL31601747 0.81 P2RY12 (0.37) CETPPOLBRXFP1F2F10
SCHEMBL31601894 0.81 PDE1B (0.34) POLBRXFP1F2F10KDM4E
SCHEMBL31601911 0.81 ALDH1A1 (0.34) CETPGPR119POLBRXFP1MEN1
SCHEMBL31601736 0.81 ALDH1A1 (0.34) POLBRXFP1MEN1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025110815-A1 IMIDAZO [1,2-B] PYRIDAZINE-BASED NOVEL COMPOUND AS CDK INHIBITOR AND USE THEREOF 아이리드비엠에스 주식회사 2025-05-30 — — WO disclosed
Send feedback